Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

BACKGROUND: The 5-year overall survival rate of lung cancer patients is approximately 15%. Most patients are diagnosed with advanced-stage disease and have shorter survival rates than patients with early-stage disease. Although screening for lung cancer has the potential to increase early diagnosis,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hocking, William G., Hu, Ping, Oken, Martin M., Winslow, Stephen D., Kvale, Paul A., Prorok, Philip C., Ragard, Lawrence R., Commins, John, Lynch, David A., Andriole, Gerald L., Buys, Saundra S., Fouad, Mona N., Fuhrman, Carl R., Isaacs, Claudine, Yokochi, Lance A., Riley, Thomas L., Pinsky, Paul F., Gohagan, John K., Berg, Christine D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2010
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2873186/
https://ncbi.nlm.nih.gov/pubmed/20442215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djq126
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller